SMN Weekly – Lenvatinib showed promising result during clinical trial

February 13, 2015 2:29 PM

3 0

A clinical trial of lenvatinib showed promising result after delaying the progression of advanced thyroid cancer by 18 months. The placebo used in the clinical trial only had four months. The result of the clinical trial was published in the New England Journal of Medicine.

For this clinical trial, Steven Sherman, M.D., an associate vice provost for clinical research, and professor and chair of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson Cancer Center in Houston treated 392 international patients from 21 countries. All patients had...

Read more

To category page